Why the study?
High serum FGF-21 levels are associated with carotid atherosclerosis and CAD, but their relationship with cfPWV in maintenance hemodialysis patients required assessment.
Is serum FGF-21 level associated with aortic stiffness in patients on maintenance hemodialysis?
Is serum FGF-21 level associated with aortic stiffness in patients on maintenance hemodialysis?
Higher serum FGF-21 levels are independently associated with increased aortic stiffness in patients undergoing maintenance hemodialysis.
Hypothesis-generating for FGF-21 as biomarker in hemodialysis; prospective studies needed before clinical adoption.
Background. Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and carotid-femoral pulse wave velocity (cfPWV) in patients on maintenance hemodialysis (HD). Methods. Blood samples and baseline characteristics were collected from 130 HD patients. Serum FGF-21 concentrations were measured with an enzyme-linked immunosorbent assay kit. Aortic stiffness was defined as a carotid-femoral pulse wave velocity (cfPWV) of more than 10 m/s. Results. Of the 130 HD patients, aortic stiffness was diagnosed in 54 (41.5%). Serum FGF-21 levels were significantly higher in those with aortic stiffness than those without <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mfenced open="(" close=")" separators="|"> <a:mrow> <a:mi>P</a:mi> <a:mo><</a:mo> <a:mn>0.001</a:mn> </a:mrow> </a:mfenced> </a:math> . The FGF-21 level was independently associated with aortic stiffness (odds ratio (OR): 1.008; 95% CI: 1.003–1.012; <f:math xmlns:f="http://www.w3.org/1998/Math/MathML" id="M2"> <f:mi>P</f:mi> <f:mo>=</f:mo> <f:mn>0.001</f:mn> </f:math> ) after adjusting for diabetes mellitus, age, hypertension, C-reactive protein, and body weight in multivariable logistic regression analysis. Multivariable forward stepwise linear regression analysis also confirmed that the logarithmically transformed FGF-21 level (β = 3.245, 95% CI: 1.593–4.987, <h:math xmlns:h="http://www.w3.org/1998/Math/MathML" id="M3"> <h:mi>P</h:mi> <h:mo><</h:mo> <h:mn>0.001</h:mn> </h:math> ) was an independent predictor of cfPWV values. The area under the receiver operating characteristic (ROC) curve predicting aortic stiffness by the serum FGF-21 level was 0.693 (95% CI: 0.606–0.771, <j:math xmlns:j="http://www.w3.org/1998/Math/MathML" id="M4"> <j:mi>P</j:mi> <j:mo><</j:mo> <j:mn>0.001</j:mn> </j:math> ). Conclusions. Serum FGF-21 level positively correlates with cfPWV and is also an independent predictor of aortic stiffness in maintenance HD patients.
No takes yet. Share an insight, caveat, or question.
Chiu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: